AOTMiT: What will the Transparency Council address today?

The agenda includes:

I. Drug evaluations under drug programs

1. Preparation of a position paper on the evaluation of the drug Ozurdex (dexamethasonum) under drug program B.70 "Treatment of patients with retinal diseases (ICD-10: H34, H35.3, H36.0)".
2. Preparation of a position paper on the evaluation of the drug Orladeyo (berotralstatum) within the framework of drug program B.122 "Preventive treatment of patients with recurrent attacks of severe hereditary angioedema (ICD-10: D84.1)".

II. Opinions on health policy programs
3. Preparation of an opinion on recommended medical technologies, activities carried out within the framework of health policy programs and the conditions for implementation of these programs - early detection of lung cancer.
4. Preparation of an opinion on the draft health policy program of the local government unit "HEALTHY AORTA". - draft preventive program for residents of the Opolskie Province for 2026-2028.
5. Preparation of an opinion on the draft health policy program of the local government unit "Program for prevention and early detection of vision and hearing defects among early school children in the municipality of Żary for 2026-2030".
6. Preparation of an opinion on the draft health policy program of the local government unit "Endometriosis Prevention Program - Luban Women in the Center of Attention".
7. Preparation of an opinion on the draft health policy program of the local government unit "Program of prevention of posture defects among children of class III of elementary schools in the Municipality of Trzebownisko in 2025-2029".
8. Preparation of an opinion on the draft health policy program of the local government unit "Health policy program of medical rehabilitation of residents of the Municipality of Baranowo for 2026-2030".

III. Opinions on the use of active substances off-registration indications
9. Preparation of an opinion on the active substance spironolactonum for an off-label indication: post-myocardial left ventricular systolic dysfunction.
10. Preparation of an opinion on the active substance bisoprololum for an off-label indication: supraventricular tachyarrhythmias - in patients over 6 years of age.
11. Preparation of an opinion on the active substance amoxicillinum for an off-label indication: infections in patients with immunodeficiency - prevention.
12.. Preparation of opinion on active substances amoxicillinum + acidum clavulanicum for an off-label indication: infections in patients with immunodeficiencies - prophylaxis.
13. Preparation of opinion on active substances sulfamethoxazolum + trimethoprimum for an off-label indication: infections in patients treated with cyclophosphamide - prophylaxis.

Source: AOTMiT